Date | Name | Activity | Value |
---|---|---|---|
Dec 30, 2024 | James L. Tyree Director | xxxxxxxxxxxxx | $8512 |
Dec 18, 2024 | Joseph Cappello Vp, Pharmaceutical Development | xxxxxxxxxxxxx | $14742 |
Sep 13, 2024 | Aladar Szalay >10% Owner | xxxxxxxxxxxxx | $171118 |
Sep 11, 2024 | Aladar Szalay >10% Owner | xxxxxxxxxxxxx | $196503 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
3,413,581 | Insider | 9.90% | 18,228,523 | |
1,165,886 | Institution | 3.38% | 6,225,831 | |
963,919 | Institution | 2.79% | 5,147,327 | |
631,307 | Institution | 1.83% | 3,371,179 | |
505,501 | Insider | 1.46% | 2,699,375 | |
266,405 | Institution | 0.77% | 1,422,603 | |
171,872 | Insider | 0.50% | 917,796 | |
82,452 | Insider | 0.24% | 440,294 | |
62,615 | Institution | 0.18% | 334,364 | |
61,963 | Institution | 0.18% | 330,882 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
963,919 | Institution | 2.79% | 5,147,327 | |
266,405 | Institution | 0.77% | 1,422,603 | |
25,224 | Institution | 0.07% | 134,696 | |
13,500 | Institution | 0.04% | 72,090 | |
7,125 | Institution | 0.02% | 38,048 | |
5,541 | Institution | 0.02% | 29,589 | |
553 | Institution | <0.01% | 2,953 |
Holder | # of Shares | Type | % Holding | Value |
---|---|---|---|---|
873,800 | Institution | 2.53% | 2,062,168 | |
292,086 | Institution | 0.85% | 689,323 | |
62,189 | Institution | 0.18% | 332,089 | |
61,963 | Institution | 0.18% | 338,318 | |
2,248 | Institution | <0.01% | 45,275 |